Jubilant Biosys Limited

Jubilant Biosys Limited is a premier Contract Research Organization (CRO) and integrated drug discovery partner serving global pharmaceutical and biotechnology companies. Established in 2001 and headquartered in Bengaluru, Karnataka, India, the company is part of the Jubilant Bhartia Group and is widely recognized for its expertise in discovery research, medicinal chemistry, biology, translational sciences, and preclinical development.

Jubilant Biosys provides comprehensive research services across multiple therapeutic areas, including oncology, metabolic disorders, central nervous system diseases, inflammation, infectious diseases, and rare diseases. Its integrated capabilities include medicinal chemistry, computational chemistry, structural biology, DMPK (Drug Metabolism and Pharmacokinetics), toxicology, biomarker research, and IND-enabling studies. The company works closely with global pharmaceutical innovators to accelerate the discovery and optimization of novel drug candidates.

With state-of-the-art research facilities in India and a growing international presence, Jubilant Biosys combines advanced scientific expertise, digital technologies, artificial intelligence, and high-throughput screening platforms to deliver high-quality research solutions. The organization follows international regulatory standards and Good Laboratory Practice (GLP) requirements while maintaining strong commitments to quality, innovation, and customer collaboration. Through continuous investment in scientific capabilities and research infrastructure, Jubilant Biosys has become one of Asia’s leading pharmaceutical discovery CROs.